Allopurinol may cut risk for neurodegenerative diseases
Xanthine dehydrogenase/oxidase blockers may reduce the risk for neurodegenerative diseases, according to a study published online May 17 in PLOS ONE.
May 19, 2023
0
4
Xanthine dehydrogenase/oxidase blockers may reduce the risk for neurodegenerative diseases, according to a study published online May 17 in PLOS ONE.
May 19, 2023
0
4
A new study led by researchers at Brown University's Carney Institute for Brain Science offers a blueprint to help scientists prevent and reverse motor deficits that occur in old age.
May 11, 2023
0
150
University of Alberta researchers have identified a neurochemical marker related to the loss of motor function and communication breakdown between the primary motor cortex—the part of the brain that controls our muscles—and ...
May 4, 2023
0
443
Researchers at Nagoya University in Japan have discovered a receptor, sigma-1 receptor, and a protein, ATAD3A, that are associated with Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease. Since there ...
Apr 26, 2023
0
2
Progressive loss of neurons is the underlying cause for a diverse spectrum of severe diseases called neurodegenerative diseases, which include Parkinson's disease, amyotrophic lateral sclerosis (ALS) and retinitis pigmentosa. ...
Apr 20, 2023
0
87
People who have lost control of their legs following a spinal cord injury may walk again someday. A research team affiliated with Université Laval and the CHU de Québec-Université Laval Research Center has pinpointed a ...
Apr 19, 2023
0
134
A randomized clinical trial is looking at whether fecal microbiota transplantation (FMT) from healthy donors into adults with early-stage amyotrophic lateral sclerosis (ALS—one of the most common forms of motor neuron disease) ...
Apr 17, 2023
0
10
The spinal cord acts as a messenger, carrying signals between the brain and body to regulate everything from breathing to movement. While the spinal cord is known to play an essential role in relaying pain signals, technology ...
Mar 21, 2023
0
22
In virtually all persons with amyotrophic lateral sclerosis (ALS) and in up to half of all cases of Alzheimer's disease (AD) and frontotemporal dementia, a protein called TDP-43 is lost from its normal location in the nucleus ...
Mar 16, 2023
0
80
University of Malta researchers have discovered a potential new drug target for amyotrophic lateral sclerosis (ALS), according to a new study published in the Neurobiology of Aging journal.
Mar 14, 2023
0
3